Canada Markets close in 36 mins

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7850+0.1050 (+6.25%)
As of 03:23PM EST. Market open.
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -0.46
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.8900
52 Week Low 31.4600
50-Day Moving Average 31.8958
200-Day Moving Average 32.1946

Share Statistics

Avg Vol (3 month) 3248.9k
Avg Vol (10 day) 3171.15k
Shares Outstanding 514.64M
Implied Shares Outstanding 6N/A
Float 811.63M
% Held by Insiders 123.32%
% Held by Institutions 116.22%
Shares Short (Oct. 28, 2021) 4115.28k
Short Ratio (Oct. 28, 2021) 40.41
Short % of Float (Oct. 28, 2021) 40.82%
Short % of Shares Outstanding (Oct. 28, 2021) 40.69%
Shares Short (prior month Sep. 29, 2021) 468.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul. 26, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:15464
Last Split Date 3Jul. 26, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.68%
Return on Equity (ttm)-88.90%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.82M
Net Income Avi to Common (ttm)-4.16M
Diluted EPS (ttm)-0.3130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.85M
Total Cash Per Share (mrq)0.64
Total Debt (mrq)562.09k
Total Debt/Equity (mrq)5.42
Current Ratio (mrq)16.09
Book Value Per Share (mrq)-0.19

Cash Flow Statement

Operating Cash Flow (ttm)-2.71M
Levered Free Cash Flow (ttm)-1.35M